IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly.
Chiloiro S, Giampietro A, Giambò P, Costanza F, Mattogno PP, Lauretti L, Calandrelli R, Gaudino S, Gessi M, Rindi G, Olivi A, De Marinis L, Doglietto F, Bianchi A, Pontecorvi A, Giustina A.
Chiloiro S, et al. Among authors: bianchi a.
Pituitary. 2024 Dec 26;28(1):7. doi: 10.1007/s11102-024-01479-9.
Pituitary. 2024.
PMID: 39724447